Thermo Fisher Scientific Improves Cancer Diagnostics for West of Scotland Regional Cytogenetics Service
News Feb 23, 2010
Thermo Fisher Scientific Inc. has announced that the West of Scotland Regional Cytogenetics Service has chosen the Thermo Scientific Varistain Gemini ES banding machine and Thermo Scientific ClearVue automated coverslipping machine for improved automation in the postnatal laboratory at its Department of Cytogenetics.
The Varistain Gemini ES is setting new standards for the efficiency of slide banding at the facility, reducing the slide-making and banding workload of the technical staff by nearly 50 percent.
In addition, the ClearVue solves the workflow hassles facing the laboratory, delivering the speed and precision that the postnatal division demands. The coverslipping machine ensures that each slide is uniform in both the placement of the coverslip and the depth of the mountant, improving the procedure.
The West of Scotland Regional Cytogenetics Service provides assistance to approximately three million people in western Scotland. The postnatal laboratory is using a full range of standard cytogenetic techniques and molecular cytogenetic technology to provide comprehensive chromosome analysis for both constitutional and acquired abnormalities.
The laboratory processes approximately 6,500 analyzes per year: nearly 2,800 of these are postnatal referrals. With such a high turnaround, the laboratory recognized that it needed to implement automated procedures to improve reporting times, quality and success rates.
Prior to installing the Thermo Scientific instrumentation, the postnatal laboratory experienced challenges with manual coverslipping and inconsistent speed in its manual banding process. The division needed an automated solution to increase throughput of blood samples, ensuring more efficient sample turnaround, slide preparation and reporting of results.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Molecular Mechanism That Enable Neuronal Connections to Change With Development DiscoveredNews
Researchers from King's College London have discovered a molecular mechanism that enables neuronal connections to change through experience, thus fuelling learning and memory formation.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018